Avivagen (TSXV:VIV) Price-to-Operating-Cash-Flow : (As of May. 19, 2024)

View and export this data going back to 2003. Start your Free Trial

What is Avivagen Price-to-Operating-Cash-Flow?

As of today (2024-05-19), Avivagen's share price is C$0.005. Avivagen's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 was C$-0.02. Hence, Avivagen's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Avivagen's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSXV:VIV's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.75
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Avivagen's Cash Flow from Operations per share for the three months ended in Jul. 2023 was C$0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 was C$-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 22.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.70% per year.

During the past 13 years, Avivagen's highest 3-Year average Operating Cash Flow per Share Growth Rate was 32.50% per year. The lowest was -16.00% per year. And the median was 14.40% per year.

Avivagen Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Avivagen's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Price-to-Operating-Cash-Flow Chart

Avivagen Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Avivagen Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Avivagen's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avivagen's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Avivagen's Price-to-Operating-Cash-Flow falls into.

Avivagen Price-to-Operating-Cash-Flow Calculation

Avivagen's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.005	/	-0.016
	=

Avivagen's Share Price of today is C$0.005.
Avivagen's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Avivagen Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Avivagen's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Avivagen (TSXV:VIV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

VIVXF:USA

Address

100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6

Website

https://www.avivagen.com

Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.